2,5-Dimethoxy-4-isobutylamphetamine
Pharmaceutical compound From Wikipedia, the free encyclopedia
2,5-Dimethoxy-4-isobutylamphetamine (DOIB or DOiBu) is a serotonin 5-HT2A receptor agonist, serotonergic psychedelic, and anti-inflammatory drug of the phenethylamine, amphetamine, and DOx families.[1][2][3][4][5] It is part of the series of straight-chain and branched-chain 4-alkylated DOx drugs that also includes DOM, DOET, DOPR, DOBU, DOAM, and DOHx, among others.[4]
![]() | |
Clinical data | |
---|---|
Other names | 2,5-Dimethoxy-4-isobutylamphetamine; 4-Isobutyl-2,5-dimethoxyamphetamine; DOIB; DOiBu; 2,5-Dimethoxy-4-(2-methylpropyl)amphetamine |
Routes of administration | Oral |
Drug class | Serotonin 5-HT2A receptor agonist; Serotonergic psychedelic; Hallucinogen; Anti-inflammatory drug |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
ChEMBL | |
Chemical and physical data | |
Formula | C15H25NO2 |
Molar mass | 251.370 g·mol−1 |
3D model (JSmol) | |
| |
|
The drug is a full agonist of the serotonin 5-HT2A receptor, with an EC50 of 12.6 nM and an Emax of 98.8%, both for calcium mobilization.[5] It is about one-third as potent as DOM in rodent drug discrimination tests and also substitutes for LSD in these tests.[3][6][1][2] In humans, DOIB is active at doses of 10 to 15 mg orally, and hence is also about one-third as potent as DOM in humans as in rodents.[2][3][7][8][9]
In addition to its psychedelic effects, DOIB has highly potent anti-inflammatory effects in preclinical research.[5] It was more potent than almost any other tested psychedelic.[5] The drug was notably more potent than (R)-DOI, but was less potent than 2C-I (the most potent assessed compound).[5]
Some other notable analogues of DOIB include DOBU (n-butyl), DOSB (sec-butyl), and DOTB (tert-butyl).[1][2][7][8][9]

See also
References
External links
Wikiwand - on
Seamless Wikipedia browsing. On steroids.